Cite
HARVARD Citation
Kadalayil, L. et al. (2017). Germline variation in ADAMTSL1 is associated with prognosis following breast cancer treatment in young women. Nature communications. 8 (1), pp. 1-12. [Online].
This is an interim version of our Electronic Legal Deposit Catalogue-eJournals and eBooks while we continue to recover from a cyber-attack.
Kadalayil, L. et al. (2017). Germline variation in ADAMTSL1 is associated with prognosis following breast cancer treatment in young women. Nature communications. 8 (1), pp. 1-12. [Online].